Drugs / N-TEC
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT06163573 | Jun 2024 → Sep 2028 expected | osteoarthritis, knee | University Hospital, Basel, Switzerland | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | N-TEC | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06163573 ↗ |
| Route | Other | “The IMP is implanted in the knee at the patellofemoral joint.” NCT06163573 ↗ |